Related references
Note: Only part of the references are listed.Factors that protect the diabetic vasculature
Christian Rask-Madsen et al.
NATURE MEDICINE (2010)
Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
Jian Xu et al.
CIRCULATION (2009)
Mice deficient in PKCβ and apolipoprotein E display decreased atherosclerosis
Evis Harja et al.
FASEB JOURNAL (2009)
Nrf2:INrf2 (Keap1) signaling in oxidative stress
James W. Kaspar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy
Pedro Geraldes et al.
NATURE MEDICINE (2009)
Prolonged Effect of Intensive Therapy on the Risk of Retinopathy Complications in Patients With Type 1 Diabetes Mellitus
ARCHIVES OF OPHTHALMOLOGY (2008)
Protein kinase C-β inhibition for diabetic kidney disease
Katherine R. Tuttle
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
R. Simo et al.
DIABETOLOGIA (2008)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 Pathway
Pedro Geraldes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
Assam El-Osta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Structural basis of protein kinase C isoform function
Susan F. Steinberg
PHYSIOLOGICAL REVIEWS (2008)
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
Berend Isermann et al.
NATURE MEDICINE (2007)
A long-term effect of epalrestat on motor conduction velocity of diabetic patients: ARI-Diabetes Complications Trial (ADCT)
Kempei Matsuoka et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity
P. Newsholme et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration - The 50-year medalist study
Hillary A. Keenan et al.
DIABETES CARE (2007)
The role of protein kinase C activation and the vascular complications of diabetes
Net Das Evcimen et al.
PHARMACOLOGICAL RESEARCH (2007)
Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice
M.-L. Brezniceanu et al.
KIDNEY INTERNATIONAL (2007)
Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss
H. J. Baelde et al.
KIDNEY INTERNATIONAL (2007)
Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis
Xiaolei Zhu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Vascular lipotoxicity: Endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats
Ichiro Chinen et al.
ENDOCRINOLOGY (2007)
Role of the VEGF-A signaling pathway in the glomerulus: Evidence for crosstalk between components of the glomerular filtration barrier
Vera Eremina et al.
NEPHRON PHYSIOLOGY (2007)
Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes
Christian Rask-Madsen et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cβ -: Null mice
Yuzuru Ohshiro et al.
DIABETES (2006)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
B Hohenstein et al.
KIDNEY INTERNATIONAL (2006)
Glucose-6-phosphate dehydrogenase activity and NADPH/NADP+ ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat
M Díaz-Flores et al.
LIFE SCIENCES (2006)
Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia
ZH He et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
K Naruse et al.
DIABETES (2006)
Neuropathy among the Diabetes Control and Complications Trial cohort 8 years after trial completion
CL Martin et al.
DIABETES CARE (2006)
Hexosamines, insulin resistance, and the complications of diabetes: current status
MG Buse
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex
YZ Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation
MG Rosca et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Molecular targets of diabetic cardiovascular complications
FK Ahmad et al.
CURRENT DRUG TARGETS (2005)
Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney
EA Lee et al.
KIDNEY INTERNATIONAL (2005)
Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy
Y Kanesaki et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes
BF Schrijvers et al.
HORMONE AND METABOLIC RESEARCH (2005)
Upstream stimulatory factor (USF) proteins induce human TGF-β1 gene activation via the glucose-response element-1013/-1002 in mesangial cells -: Up-regulation of USF activity by the hexosamine biosynthetic pathway
C Weigert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy
HJ Baelde et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Microvascular complications of diabetes
ZH He et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2004)
Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: Role of advanced glycation end products
M Lassila et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Advanced glycation end-product cross-link breakers - A novel approach to cardiovascular pathologies related to the aging process
GL Bakris et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis
JM Forbes et al.
DIABETES (2004)
Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes
E Bortoloso et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Oxidative stress is associated with adiposity and insulin resistance in men
H Urakawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Translocation of glomerular p47phox and p67phox by protein kinase C-β activation is required for oxidative stress in diabetic nephropathy
M Kitada et al.
DIABETES (2003)
Protein kinase Cβ selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons
H Kim et al.
DIABETES (2003)
Contribution of polyol pathway to diabetes-induced oxidative stress
SSM Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury
ZM Zhou et al.
CIRCULATION (2003)
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes
R Candido et al.
CIRCULATION RESEARCH (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Central role of RAGE-dependent neointimal expansion in arterial restenosis
T Sakaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes
T Yokota et al.
DIABETES (2003)
Molecular understanding of hyperglycemia's adverse effects for diabetic complications
MJ Sheetz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice
LG Bucciarelli et al.
CIRCULATION (2002)
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes - Results of the HOPE study and MICRO-HOPE substudy
E Lonn et al.
DIABETES CARE (2002)
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
A Flyvbjerg et al.
DIABETES (2002)
Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C β2 activation and diabetes
KJ Way et al.
DIABETES (2002)
Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy
M Enge et al.
EMBO JOURNAL (2002)
Thrombomodulin deficiency in human diabetic nerve microvasculature
CE Hafer-Macko et al.
DIABETES (2002)
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses
G Basta et al.
CIRCULATION (2002)
Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization
K Suzuma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Inhibition of protein kinase Cβ prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans
JA Beckman et al.
CIRCULATION RESEARCH (2002)
Mesangial cell filamentous actin disassembly and hypocontractility in high glucose are mediated by PKC-zeta
JA Dlugosz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Diabetes-associated sustained activation of the transcription factor nuclear factor-κB
A Bierhaus et al.
DIABETES (2001)
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site
XL Du et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
The regulation of the induction of vascular endothelial growth factor at the onset of diabetes in spontaneously diabetic rats
L Braun et al.
LIFE SCIENCES (2001)
Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy - A 52-week multicenter placebo-controlled double-blind parallel group study
N Hotta et al.
DIABETES CARE (2001)
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser1179
M Montagnani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis
Y Masuda et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability
XY Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells
JD Ahn et al.
DIABETOLOGIA (2001)
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells
K Suzuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells
ZQ Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
RAGE: A new target for the prevention and treatment of the vascular and inflammatory complications of diabetes
AM Schmidt et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
T Inoguchi et al.
DIABETES (2000)
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
XL Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm
A Mezzetti et al.
CARDIOVASCULAR RESEARCH (2000)
Induction of endothelin-1 expression by glucose - An effect of protein kinase C activation
JY Park et al.
DIABETES (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo A specific vascular action of insulin
K Kuboki et al.
CIRCULATION (2000)
Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle
K Cusi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Vitamin E supplementation and cardiovascular events in high-risk patients
S Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
